|
|
|
|
|
|
最高研发阶段批准上市 |
首次获批国家/地区- |
首次获批日期1942-12-31 |
Clinical Trial Randomized, Placebo-controlled, Using Dapsone as a Neuroprotector During Acute Ischemia Stroke
The main purpose of the study is to get information about the safety and efficacy of treatment with Dapsone to prevent the disability after ischemic Stroke, in patients diagnosed with anterior territory brain infarct.
100 项与 Cidat Sa De Cv 相关的临床结果
0 项与 Cidat Sa De Cv 相关的专利(医药)
100 项与 Cidat Sa De Cv 相关的药物交易
100 项与 Cidat Sa De Cv 相关的转化医学